top of page


National Study Highlights Need for Better Standards of Care in PMR
Our team has published a national survey of Australian rheumatologists examining how polymyalgia rheumatica (PMR) is diagnosed and managed across the country. Led by rheumatologist Dr Jessica Leung, the article titled "Experience of Australian rheumatologists managing polymyalgia rheumatica: results from a national survey" was published in the Internal Medicine Journal. Dr Leung's study found considerable variation in clinical practice, including differences in diagnostic app

AustPMRGCA
Jun 8


Dr Claire Owen Receives National Research Award for PMR Project
Congratulations to Dr Claire Owen on being awarded the Australian Rheumatology Association (ARA) Research Fund / New Zealand Rheumatology Association Philip Robinson Memorial Award, presented at the ARA Annual Scientific Meeting on the Gold Coast. The project will use advanced proteomics technology to search for a unique "protein fingerprint" of polymyalgia rheumatica in blood samples. PMR remains difficult to diagnose, and there are currently no definitive blood tests availa

AustPMRGCA
May 19


Prestigious NHMRC Scholarships Awarded to AustPMRGCA Researchers
Two members of the AustPMRGCA group have been awarded highly competitive National Health and Medical Research Council (NHMRC) Postgraduate Scholarships. Saskia Rowson's PhD research will investigate how exercise can complement the management of polymyalgia rheumatica, while Dr Victor Yang's PhD focuses on identifying protein signatures in the blood of people with PMR. These scholarships provide support for the next generation of PMR research and reflect growing national recog

AustPMRGCA
Feb 1


International Collaboration Brings Patient Voices to the Forefront of PMR Research
A new international review involving Dr Claire Owen and collaborators across Europe has explored the lived experiences of people with polymyalgia rheumatica. The study found that many patients experience delays in diagnosis, uncertainty about their condition, and challenges balancing symptom relief against the side effects of long-term steroid treatment. Importantly, researchers also identified differences between how patients describe their experiences and the language commo

AustPMRGCA
Jan 16


PET Scans and AI Improve Understanding of Atypical PMR
Researchers from the AustPMRGCA group have demonstrated that specialised PET/CT imaging can identify characteristic PMR patterns even in patients whose symptoms do not fit traditional diagnostic criteria. The paper, titled "Polymyalgia rheumatica patients presenting with atypical clinical features still exhibit characteristic 18F-FDG PET/CT findings", was published in the European Journal of Nuclear Medicine and Molecular Imaging. The study also showed that an artificial inte

AustPMRGCA
Dec 5, 2025
Search


Historic $100 Million Investment Announced for Arthritis and Musculoskeletal Research
A major milestone has been reached for Australians living with arthritis and musculoskeletal conditions, with the Australian Government announcing a new $100 million Medical Research Future Fund (MRFF) Mission dedicated to arthritis and musculoskeletal health. Nearly seven million Australians are affected by these conditions, including many people living with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA). This landmark investment recognises the significant impac

AustPMRGCA
Jun 11


Baricitinib Trial Shows Promise as a Steroid-Sparing Treatment for PMR
New results presented at the EULAR 2026 Congress suggest that baricitinib may help people with newly diagnosed polymyalgia rheumatica achieve remission while substantially reducing their reliance on glucocorticoids. In the Phase 3 JAK-SPARE trial, nearly two-thirds of patients receiving baricitinib achieved glucocorticoid-free remission within 16 weeks, compared with fewer than one in five patients receiving placebo. Patients treated with baricitinib also required significant

AustPMRGCA
Jun 7


New International Guidelines Published for PMR and GCA
The European Alliance of Associations for Rheumatology (EULAR) has released updated international recommendations for the diagnosis and management of polymyalgia rheumatica (PMR) and large vessel vasculitis, including giant cell arteritis (GCA). Developed by an international expert task force representing 13 countries, the recommendations place a strong emphasis on early specialist assessment, accurate diagnosis using imaging and other objective tests, and shared decision-mak

AustPMRGCA
Jun 6


Landmark International Trial Demonstrates New Treatment Option for Relapsing PMR
A major international clinical trial published in The New England Journal of Medicine has shown that secukinumab can significantly improve outcomes for people with relapsing polymyalgia rheumatica (PMR). The Phase 3 REPLENISH trial found that patients receiving secukinumab alongside a structured steroid taper were approximately twice as likely to achieve sustained remission after one year compared with patients receiving standard treatment alone. We were proud to have recruit

AustPMRGCA
Jun 3
bottom of page
.png)